131 related articles for article (PubMed ID: 36326326)
1. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat!
Bostancı Eİ; Durmuş Y; Çöteli ASD; Kayakçıoğlu F; Boran N
Turk J Med Sci; 2022 Jun; 52(3):871. PubMed ID: 36326326
[No Abstract] [Full Text] [Related]
2. Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat!
İşçi Bostancı E; Durmuş Y; Duru Çöteli AS; Kayıkçıoğlu F; Boran N
Turk J Med Sci; 2021 Aug; 51(4):2066-2072. PubMed ID: 34013707
[TBL] [Abstract][Full Text] [Related]
3. Quantitative next-generation sequencing-based analysis indicates progressive accumulation of microsatellite instability between atypical hyperplasia/endometrial intraepithelial neoplasia and paired endometrioid endometrial carcinoma.
Chapel DB; Patil SA; Plagov A; Puranik R; Mendybaeva A; Steinhardt G; Wanjari P; Lastra RR; Kadri S; Segal JP; Ritterhouse LL
Mod Pathol; 2019 Oct; 32(10):1508-1520. PubMed ID: 31186530
[TBL] [Abstract][Full Text] [Related]
4. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
Vetter MH; Smith B; Benedict J; Hade EM; Bixel K; Copeland LJ; Cohn DE; Fowler JM; O'Malley D; Salani R; Backes FJ
Am J Obstet Gynecol; 2020 Jan; 222(1):60.e1-60.e7. PubMed ID: 31401259
[TBL] [Abstract][Full Text] [Related]
5. Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma.
Russo M; Broach J; Sheldon K; Houser KR; Liu DJ; Kesterson J; Phaeton R; Hossler C; Hempel N; Baker M; Newell JM; Zaino R; Warrick JI
Hum Pathol; 2017 Sep; 67():69-77. PubMed ID: 28712776
[TBL] [Abstract][Full Text] [Related]
6. Predictive accuracy of hormone receptors in conservatively treated endometrial hyperplasia and early endometrioid carcinoma.
Raffone A; Travaglino A; Mascolo M; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2020 Jan; 99(1):140. PubMed ID: 31529482
[No Abstract] [Full Text] [Related]
7. Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment.
Raffone A; Travaglino A; Saccone G; Di Maio A; Mollo A; Mascolo M; De Rosa R; De Placido G; Insabato L; Zullo F
Gynecol Endocrinol; 2019 Nov; 35(11):932-937. PubMed ID: 31165649
[No Abstract] [Full Text] [Related]
8. Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer.
Westin SN; Fellman B; Sun CC; Broaddus RR; Woodall ML; Pal N; Urbauer DL; Ramondetta LM; Schmeler KM; Soliman PT; Fleming ND; Burzawa JK; Nick AM; Milbourne AM; Yuan Y; Lu KH; Bodurka DC; Coleman RL; Yates MS
Am J Obstet Gynecol; 2021 Feb; 224(2):191.e1-191.e15. PubMed ID: 32805208
[TBL] [Abstract][Full Text] [Related]
9. YTHDF2 is a novel diagnostic marker of endometrial adenocarcinoma and endometrial atypical hyperplasia/ intraepithelial neoplasia.
Bian PP; Liu SY; Luo QP; Xiong ZT
Pathol Res Pract; 2022 Jun; 234():153919. PubMed ID: 35512522
[TBL] [Abstract][Full Text] [Related]
10. Conservative management of patients with endometrial intraepithelial neoplasia (EIN): Factors that could affect response and pregnancy rates.
Iavazzo C; Gkegkes ID
Turk J Med Sci; 2022 Jun; 52(3):870. PubMed ID: 36326317
[No Abstract] [Full Text] [Related]
11. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
Xiong Y; Xiong YY; Zhou YF
Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical predictive markers of response to conservative treatment of endometrial hyperplasia and early endometrial cancer: A systematic review.
Travaglino A; Raffone A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
Acta Obstet Gynecol Scand; 2019 Sep; 98(9):1086-1099. PubMed ID: 30793281
[TBL] [Abstract][Full Text] [Related]
13. Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.
Ambros RA; Sherman ME; Zahn CM; Bitterman P; Kurman RJ
Hum Pathol; 1995 Nov; 26(11):1260-7. PubMed ID: 7590702
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of hysteroscopic resection of endometrial atypical hyperplasia-endometrioid intraepithelial neoplasia and early-stage cancer in combination with megestrol acetate.
Masciullo V; Trivellizzi N; Zannoni G; Catena U; Moroni R; Fanfani F; Scambia G
Am J Obstet Gynecol; 2021 Apr; 224(4):408-410. PubMed ID: 33385345
[No Abstract] [Full Text] [Related]
15. Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia.
Rubatt JM; Slomovitz BM; Burke TW; Broaddus RR
Gynecol Oncol; 2005 Nov; 99(2):472-6. PubMed ID: 16099019
[TBL] [Abstract][Full Text] [Related]
16. Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma.
Russo M; Newell JM; Budurlean L; Houser KR; Sheldon K; Kesterson J; Phaeton R; Hossler C; Rosenberg J; DeGraff D; Shuman L; Broach JR; Warrick JI
Cancer; 2020 Jun; 126(12):2775-2783. PubMed ID: 32187665
[TBL] [Abstract][Full Text] [Related]
17. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
Zhou WX; Liang ZY; Gao J; Liu TH
Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
[TBL] [Abstract][Full Text] [Related]
18. Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia.
Zhang X; Chen D; Zhao X; Wang C; He Y; Chen Y; Wang J; Shen D
Pathol Res Pract; 2023 Jan; 241():154278. PubMed ID: 36580798
[TBL] [Abstract][Full Text] [Related]
19. [Fertility-sparing management of endometrial cancer and atypical hyperplasia].
Gonthier C; Trefoux-Bourdet A; Luton D; Koskas M
Gynecol Obstet Fertil Senol; 2017 Feb; 45(2):112-118. PubMed ID: 28368791
[TBL] [Abstract][Full Text] [Related]
20. Development of endometrioid adenocarcinoma despite Levonorgestrel-releasing intrauterine system: a case report with discussion and review of the RCOG/BSGE Guideline on the Management of Endometrial Hyperplasia.
van der Meer AC; Hanna LS
Clin Obes; 2017 Feb; 7(1):54-57. PubMed ID: 27984850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
